Medicinal composition and its preparing method

A composition and drug technology, applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve lipid drugs such as niacin, pravastatin, lovastatin; thrombolytic drugs such as warfarin, heparin, urokinase, Streptokinase, insignificant tonic effect, low bioavailability and other problems, to achieve the effect of increasing the number of cell divisions, improving the quality of life, and strong physiological activity

Inactive Publication Date: 2007-03-28
BEIJING QI YUAN YI DE PHARMA RESEARCH CENTER
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, western medicines such as nitroglycerin, nitrate preparations such as nitroglycerin, sorbitol mononitrate, etc. for the treatment of coronary heart disease; Proprolol, pindolol, metoprolol; calcium channel blockers such as verapamil, nifedipine, diltiazem; antiplatelet drugs such as aspirin, dipyridamole, besulfazone; Blood lipid adjustment drugs such as niacin, pravastatin, and lovastatin; thrombolytic drugs such as warfarin, heparin, urokinase, and streptokinase; however, during the course of medication, it was found that these drugs can relieve acute symptoms, but they are not yet effective for the cause However, traditional Chinese medicines such as Compound Danshen Dripping Pills, Compou

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0116] Example 1: 10 parts of ginseng, 0.1 part of total glycosides of paeony

[0117] Take the ginseng medicinal material, add 8 times the volume of 70% ethanol to reflux and extract 3 times, each time for 1 hour, combine the extracts, recover the ethanol under reduced pressure to 60°C, measure the relative density to 1.05-1.15, add 4 times the volume of the medicinal material in water to dissolve, Filter, the filtrate passes through ZTC-1 type macroporous adsorption resin at a speed of 0.5ml / g medicinal material.min, wash impurities with 7 times of resin volume water and 5 times of resin volume 10% ethanol successively, and then use 60% of 5 times of resin volume Desorb with ethanol, collect the desorbed liquid, recover the ethanol under reduced pressure to 60°C, measure the relative density to 1.05-1.15, and dry it to obtain ginseng extract; mix the ginseng extract and total glucosides of paeony evenly, add water for injection, stir to dissolve, and boil Finally, add 0.5% (...

Embodiment 2

[0118] Example 2: 3000 parts of ginseng and 1 part of total glucosides of paeony

[0119] Take the ginseng medicinal material, add 6 times the volume of 60% ethanol to reflux and extract twice, each time for 2.5 hours, combine the extracts, recover the ethanol under reduced pressure to 60°C, measure the relative density to 1.05-1.15, add 5 times the volume of the medicinal material in water to dissolve, Filter, the filtrate passes through ZTC-1 type macroporous adsorption resin at a speed of 0.5ml / g medicinal material.min, wash impurities with water 7 times the volume of the resin and 10% ethanol 4 times the volume of the resin successively, and then use 60% of the volume 4 times the volume of the resin Desorb with ethanol, collect the desorbed liquid, recover the ethanol under reduced pressure to 60°C, measure the relative density to 1.05-1.15, and dry to obtain ginseng extract; add water for injection and stir to dissolve, boil, adjust the pH value to between 5.0-7.0, The me...

Embodiment 3

[0120] Embodiment 3: 10000 parts of ginseng, 50 parts of total glycosides of paeony

[0121]Take the ginseng medicinal material, add 10 times the volume of 80% ethanol to reflux and extract twice, each time for 2.0 hours, combine the extracts, recover the ethanol under reduced pressure and measure the relative density to 1.05-1.15 at 60°C, add 3 times the volume of the medicinal material in water to dissolve, Filtrate, the filtrate passes through ZTC-1 type macroporous adsorption resin at a speed of 0.3-0.8ml / g medicinal material min, wash impurities with water 5 times the volume of the resin and 8% ethanol 3 times the volume of the resin in turn, and then use 4 times the volume of the resin Desorb with 70% ethanol, collect the desorption liquid, recover the ethanol under reduced pressure to 60°C, measure the relative density to 1.05-1.15, and dry to obtain the ginseng extract; add water for injection to dissolve, adjust the pH value between 5.0-7.0, and prepare the liquid for ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a medicine composition for curing angiocardiopathy and cerebrovascular diseases and its preparation method. The prescription of said medicine composition is formed from ginseng (or ginseng stem and leaf portion or red ginseng or pilose asiabell root) or its extract and red peony total glucoside or white peony total glucoside. Said medicine composition can be made into injection preparation and oral preparation.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, and provides a preparation method of the composition, which belongs to the technical field of medicines. technical background [0002] Cardiovascular and cerebrovascular diseases are the first major diseases that seriously threaten human life and health today, and have become the first and second causes of death in most countries in the world. It not only has a high fatality rate, but also leads to disability of patients after its onset The rate is also very high. At present, 2.6 million people die from cardiovascular and cerebrovascular diseases in my country every year, and one person dies from such diseases every 12 seconds, among which coronary heart disease ranks first. It is reported that coronary heart disease has become an important disease that threatens the lives and health of the public. It is estimated that more than 1 million pe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/258A61K9/14A61K9/16A61K9/20A61K9/48A61P9/10A61K31/704
Inventor 于文风
Owner BEIJING QI YUAN YI DE PHARMA RESEARCH CENTER
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap